119 related articles for article (PubMed ID: 36301046)
1. Comparison of Sodium Bicarbonate and Lactated Ringers Hydration for High-dose Methotrexate Chemotherapy in Children.
Kendrick J; Jacques L; Baadjes B; Carr R
J Pediatr Hematol Oncol; 2022 Nov; 44(8):442-445. PubMed ID: 36301046
[TBL] [Abstract][Full Text] [Related]
2. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience.
Diachinsky M; Tran T; Jupp J; McKinnon K
J Oncol Pharm Pract; 2021 Jan; 27(1):119-127. PubMed ID: 32316877
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage.
Roy AM; Lei M; Lou U
J Oncol Pharm Pract; 2019 Dec; 25(8):1860-1866. PubMed ID: 30636529
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization.
Heisler RD; Kelly JJ; Abedinzadegan Abdi S; Hawker JL; Fong LG; Quon JL; Rioux JZ; Jupp JC
Support Care Cancer; 2022 Feb; 30(2):1273-1281. PubMed ID: 34471970
[TBL] [Abstract][Full Text] [Related]
5. Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage.
Mangum R; Bernhardt MB; Cheng WS; Schafer ES; Berg SL; Foster JH
Pediatr Blood Cancer; 2020 Sep; 67(9):e28334. PubMed ID: 32608575
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate.
Kramer E; Filtz M; Pace M
J Oncol Pharm Pract; 2021 Jan; 27(1):26-32. PubMed ID: 32164493
[TBL] [Abstract][Full Text] [Related]
7. Oral Methods of Urinary Alkalinization for High-dose Methotrexate Administration: Alternatives to Intravenous Sodium Bicarbonate During a Critical Drug Shortage.
Visage R; Kaiser N; Williams M; Kim A
J Pediatr Hematol Oncol; 2019 Jul; 41(5):371-375. PubMed ID: 30475303
[TBL] [Abstract][Full Text] [Related]
8. Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate.
Clemmons AB; Chase A; Duong P; Waller JL; Saunders K; Bryan L
Support Care Cancer; 2021 Mar; 29(3):1527-1534. PubMed ID: 32725375
[TBL] [Abstract][Full Text] [Related]
9. Retrospective evaluation of sodium acetate use for urine alkalinization in patients receiving high dose methotrexate.
Perkey CL; Flynn LA; Lentz K; Butler S
J Oncol Pharm Pract; 2023 Jan; 29(1):119-124. PubMed ID: 34931924
[TBL] [Abstract][Full Text] [Related]
10. Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.
Rouch JA; Burton B; Dabb A; Brown V; Seung AH; Kinsman K; Holdhoff M
J Oncol Pharm Pract; 2017 Jan; 23(1):3-9. PubMed ID: 26467268
[TBL] [Abstract][Full Text] [Related]
11. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
[TBL] [Abstract][Full Text] [Related]
12. A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate.
Reed DR; Pierce EJ; Sen JM; Keng MK
Cancer Manag Res; 2019; 11():8065-8072. PubMed ID: 31507329
[TBL] [Abstract][Full Text] [Related]
13. Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma.
Pampín R; Labeaga Y; Rodríguez B; Fernández B; Fernández R; Carbajales M
J Oncol Pharm Pract; 2020 Apr; 26(3):549-555. PubMed ID: 31156052
[TBL] [Abstract][Full Text] [Related]
14. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
[TBL] [Abstract][Full Text] [Related]
15. High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance.
Chen AR; Wang YM; Lin M; Kuo DJ
Cureus; 2020 Jun; 12(6):e8674. PubMed ID: 32699674
[TBL] [Abstract][Full Text] [Related]
16. The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients.
Traivaree C; Likasitthananon N; Monsereenusorn C; Rujkijyanont P
Cancer Manag Res; 2018; 10():4471-4478. PubMed ID: 30349379
[TBL] [Abstract][Full Text] [Related]
17. Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate.
Kintzel PE; Campbell AD; Yost KJ; Brinker BT; Arradaza NV; Frobish D; Wehr AM; O'Rourke TJ
J Oncol Pharm Pract; 2012 Jun; 18(2):239-44. PubMed ID: 22075004
[TBL] [Abstract][Full Text] [Related]
18. [Effect of IV hydration with sodium bicarbonate on high-dose methotrexate disposition kinetics].
Tsuda N; Goto M; Konishi H; Yamashina H
Gan To Kagaku Ryoho; 1984 Apr; 11(4):873-80. PubMed ID: 6326682
[TBL] [Abstract][Full Text] [Related]
19. Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin.
Vaishnavi K; Bansal D; Trehan A; Jain R; Attri SV
Pediatr Blood Cancer; 2018 Dec; 65(12):e27241. PubMed ID: 29768710
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate in adult oncology patients: a case-control study assessing the risk association between drug interactions and methotrexate toxicity.
Chan AJ; Rajakumar I
J Oncol Pharm Pract; 2014 Apr; 20(2):93-9. PubMed ID: 23698198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]